
Alpha Teknova Q4 Earnings Call Highlights
Alpha Teknova (NASDAQ: TKNO) executives told investors the company delivered faster growth and improved profitability metrics in 2025, and said they believe the business is approaching an "inflection point" as it scales its mix of research-grade and GMP-grade reagents. On the company's fourth-quarter and full-year 2025 earnings call, management highlighted rising clinical customer counts, improving manufacturing


















